1. ACTR-42. PI3K/mTOR PATHWAY ACTIVATION SELECTED PHASE II STUDY OF EVEROLIMUS (RAD001) WITH AND WITHOUT TEMOZOLOMIDE IN THE TREATMENT OF ADULT PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMA [NCT NCT02023905]. (11th November 2019) Authors: Taylor, Jennie; Molinaro, Annette; Rodriguez Almaraz, Eduardo; Downey, Ciara; Phillips, Joanna; Ann Oberheim-Bush, Nancy; Butowski, Nicholas; Chang, Susan; Berger, Mitchel; Prados, Michael; Haas-Kogan, Daphne; Clarke, Jennifer Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗